Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease
Aleksandra Klimkowicz-Mrowiec,1 Pawel Wolkow,2 Malgorzata Sado,3 Anna Dziubek,3 Joanna Pera,1 Tomasz Dziedzic,1 Andrzej Szczudlik,1 Agnieszka Slowik1 1Department of Neurology, Jagiellonian University, School of Medicine, Botaniczna, 2Department of Pharmacology, Jagiellonian University, School of Med...
Main Authors: | Klimkowicz-Mrowiec A, Wolkow P, Sado M, Dziubek A, Pera J, Dziedzic T, Szczudlik A, Slowik A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/influence-of-rs1080985-single-nucleotide-polymorphism-of-the-cyp2d6-ge-a13840 |
Similar Items
-
Influence of the rs1080985 Single Nucleotide Polymorphism of the CYP2D6 Gene and APOE Polymorphism on the Response to Donepezil Treatment in Patients with Alzheimer's Disease in China
by: Mengyuan Liu, et al.
Published: (2014-11-01) -
Case report on novel mutation in SPAST gene in Polish family with spastic paraplegia
by: Aleksandra Klimkowicz-Mrowiec, et al.
Published: (2019-12-01) -
Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease
by: Ping-Song Chou, et al.
Published: (2022-01-01) -
Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01) -
Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia
by: Yaowaluk T, et al.
Published: (2019-09-01)